These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 36003914)

  • 1. A nomogram risk prediction model for no-reflow after primary percutaneous coronary intervention based on rapidly accessible patient data among patients with ST-segment elevation myocardial infarction and its relationship with prognosis.
    Liu Y; Ye T; Chen K; Wu G; Xia Y; Wang X; Zong G
    Front Cardiovasc Med; 2022; 9():966299. PubMed ID: 36003914
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Construction and evaluation of nomogram model for individualized prediction of risk of major adverse cardiovascular events during hospitalization after percutaneous coronary intervention in patients with acute ST-segment elevation myocardial infarction.
    Fang C; Chen Z; Zhang J; Jin X; Yang M
    Front Cardiovasc Med; 2022; 9():1050785. PubMed ID: 36620648
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A nomogram for predicting the risk of no-reflow after primary percutaneous coronary intervention in elderly patients with ST-segment elevation myocardial infarction.
    Yang L; Cong H; Lu Y; Chen X; Liu Y
    Ann Transl Med; 2021 Jan; 9(2):126. PubMed ID: 33569428
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predictive value of triglyceride glucose index combined with neutrophil-to-lymphocyte ratio for major adverse cardiac events after PCI for acute ST-segment elevation myocardial infarction.
    Wang L; Wang Y; Wang W; Wang Z
    Sci Rep; 2024 Jun; 14(1):12634. PubMed ID: 38824158
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PTH Predicts the in-Hospital MACE After Primary Percutaneous Coronary Intervention for Acute ST-Segment Elevation Myocardial Infarction.
    Wu ZF; Su WT; Chen S; Xu BD; Zong GJ; Fang CM; Huang Z; Hu XJ; Wu GY; Ma XL
    Ther Clin Risk Manag; 2023; 19():699-712. PubMed ID: 37641783
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MELD-XI score predict no-reflow phenomenon and short-term mortality in patient with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.
    Zhang XT; Lin ZR; Zhang L; Zhao ZW; Chen LL
    BMC Cardiovasc Disord; 2022 Mar; 22(1):113. PubMed ID: 35300593
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Predictive Model for Contrast-Induced Acute Kidney Injury After Percutaneous Coronary Intervention in Elderly Patients with ST-Segment Elevation Myocardial Infarction.
    Qiu H; Zhu Y; Shen G; Wang Z; Li W
    Clin Interv Aging; 2023; 18():453-465. PubMed ID: 36987461
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In-hospital major adverse cardiovascular events after primary percutaneous coronary intervention in patients with acute ST-segment elevation myocardial infarction: a retrospective study under the China chest pain center (standard center) treatment system.
    Huang L; Zhang J; Huang Q; Cui R; Chen J
    BMC Cardiovasc Disord; 2023 Apr; 23(1):198. PubMed ID: 37069503
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Canada acute coronary syndrome risk score predicts no-/slow-reflow in ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention.
    Xie E; Li Q; Ye Z; Guo Z; Li Y; Shen N; Yu C; Gao Y; Zheng J
    Heliyon; 2023 Nov; 9(11):e21276. PubMed ID: 37920501
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Nomogram model for predicting the occurrence of no-reflow phenomenon after percutaneous coronary intervention using the lncRNA
    Hu CK; Cai RP; He L; He SR; Liao JY; Su Q
    J Thorac Dis; 2022 Jun; 14(6):2158-2168. PubMed ID: 35813727
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Usefulness of fibrinogen-to-albumin ratio to predict no-reflow and short-term prognosis in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.
    Zhao Y; Yang J; Ji Y; Wang S; Wang T; Wang F; Tang J
    Heart Vessels; 2019 Oct; 34(10):1600-1607. PubMed ID: 30993442
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of risk factors for PCI no-reflow in coronary heart disease and construction of related prediction models.
    Zhang L; Lin J; Luo L; Liu B; Zeng X
    Am J Transl Res; 2024; 16(8):3733-3741. PubMed ID: 39262730
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictive value of admission red cell distribution width-platelet ratio for no-reflow phenomenon in acute ST segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.
    Celık T; Balta S; Demır M; Yıldırım AO; Kaya MG; Ozturk C; Demırkol S; Unlu M; Kılıc S; Aydın İ; Iyısoy A
    Cardiol J; 2016; 23(1):84-92. PubMed ID: 26503078
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development and Validation of Nomogram for the Prediction of Malignant Ventricular Arrhythmia Including Circulating Inflammatory Cells in Patients with Acute ST-Segment Elevation Myocardial Infarction.
    Wang L; Yang L; Li T; Geng S
    J Inflamm Res; 2023; 16():3185-3196. PubMed ID: 37529768
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Systemic immune-inflammation index predicts no-reflow phenomenon after primary percutaneous coronary intervention.
    Esenboğa K; Kurtul A; Yamantürk YY; Tan TS; Tutar DE
    Acta Cardiol; 2022 Feb; 77(1):59-65. PubMed ID: 33612077
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Systemic Immune-Inflammation Index Predicts Impaired Myocardial Perfusion and Short-Term Mortality in ST-Segment Elevation Myocardial Infarction Patients.
    Vatan MB; Çakmak AC; Ağaç S; Eynel E; Erkan H
    Angiology; 2023 Apr; 74(4):365-373. PubMed ID: 35670358
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The value of plasma D-dimer level on admission in predicting no-reflow after primary percutaneous coronary intervention and long-term prognosis in patients with acute ST segment elevation myocardial infarction.
    Erkol A; Oduncu V; Turan B; Kılıçgedik A; Sırma D; Gözübüyük G; Karabay CY; Guler A; Dündar C; Tigen K; Pala S; Kırma C
    J Thromb Thrombolysis; 2014 Oct; 38(3):339-47. PubMed ID: 24407374
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predicting long-term prognosis after percutaneous coronary intervention in patients with new onset ST-elevation myocardial infarction: development and external validation of a nomogram model.
    Ye Z; Xu Y; Tang L; Wu M; Wu B; Zhu T; Wang J
    Cardiovasc Diabetol; 2023 Apr; 22(1):87. PubMed ID: 37055777
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nomogram for Predicting In-Hospital Mortality in Patients with Acute ST-Elevation Myocardial Infarction Complicated by Cardiogenic Shock after Primary Percutaneous Coronary Intervention.
    Wang Y; Liu L; Li X; Dang Y; Li Y; Wang J; Qi X
    J Interv Cardiol; 2022; 2022():8994106. PubMed ID: 35356419
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Establishment and validation of nomogram model for predicting major adverse cardiac events in patients with acute ST-segment elevation myocardial infarction based on glycosylated hemoglobin A1c to apolipoprotein A1 ratio: An observational study.
    Zhang KP; Guo QC; Mu N; Liu CH
    Medicine (Baltimore); 2024 Jun; 103(24):e38563. PubMed ID: 38875361
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.